Touchlight Genetics News Today

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Odimma Therapeutics, a biotechnology company specialized in personalized cancer immunotherapy announces a seed fundraising of €2 million in order to secure the preparation on its First-in-Man clinical

/PRNewswire/ -- TAAV Biomanufacturing Solutions, S.L. (TAAV), an independently operated wholly-owned subsidiary of Asklepios BioPharmaceutical, Inc. (AskBio),...

Synthetic DNA material to be used in upcoming approved Huntington's disease study in France may be key to scaling gene therapy production

ZeroHedge - On a long enough timeline, the survival rate for everyone drops to zero

The new battery technology harnesses the power of DNA to provide a safer, greener solution to generating power and has potential applications across society.

Leaders in ophthalmology drug development launch new global company to build and advance diversified portfolio of ocular therapies Eyebiotech Limited (EyeBio), a privately held ophthalmology biotechnology

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

In spite of the challenges posed by the Covid-19 pandemic, the European biotech industry has emerged stronger than ever this year. These were the key moments for the sector in 2021.

More VC investment, more unicorns, more jobs and more futurecorns